BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22306557)

  • 1. A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa.
    Geng EH; Glidden DV; Bangsberg DR; Bwana MB; Musinguzi N; Nash D; Metcalfe JZ; Yiannoutsos CT; Martin JN; Petersen ML
    Am J Epidemiol; 2012 May; 175(10):1080-7. PubMed ID: 22306557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa.
    Geng EH; Glidden DV; Emenyonu N; Musinguzi N; Bwana MB; Neilands TB; Muyindike W; Yiannoutsos CT; Deeks SG; Bangsberg DR; Martin JN
    Trop Med Int Health; 2010 Jun; 15 Suppl 1(Suppl 1):63-9. PubMed ID: 20586962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda.
    Geng EH; Bwana MB; Muyindike W; Glidden DV; Bangsberg DR; Neilands TB; Bernheimer I; Musinguzi N; Yiannoutsos CT; Martin JN
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):e64-71. PubMed ID: 23429504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy.
    Kredo T; Adeniyi FB; Bateganya M; Pienaar ED
    Cochrane Database Syst Rev; 2014 Jul; (7):CD007331. PubMed ID: 24980859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection Bias Due to Loss to Follow Up in Cohort Studies.
    Howe CJ; Cole SR; Lau B; Napravnik S; Eron JJ
    Epidemiology; 2016 Jan; 27(1):91-7. PubMed ID: 26484424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of estimates of retention in care among a cohort of HIV-positive patients in Uganda in the period before starting ART: a sampling-based approach.
    Nyakato P; Kiragga AN; Kambugu A; Bradley J; Baisley K
    BMJ Open; 2018 Apr; 8(4):e017487. PubMed ID: 29678963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study.
    Geng EH; Odeny TA; Lyamuya RE; Nakiwogga-Muwanga A; Diero L; Bwana M; Muyindike W; Braitstein P; Somi GR; Kambugu A; Bukusi EA; Wenger M; Wools-Kaloustian KK; Glidden DV; Yiannoutsos CT; Martin JN
    Lancet HIV; 2015 Mar; 2(3):e107-16. PubMed ID: 26424542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
    Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
    BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care Among HIV-Infected Patients on Antiretroviral Therapy in Eastern Africa: Application of a Sampling-Based Approach.
    Geng EH; Odeny TA; Lyamuya R; Nakiwogga-Muwanga A; Diero L; Bwana M; Braitstein P; Somi G; Kambugu A; Bukusi E; Wenger M; Neilands TB; Glidden DV; Wools-Kaloustian K; Yiannoutsos C; Martin J
    Clin Infect Dis; 2016 Apr; 62(7):935-944. PubMed ID: 26679625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
    Sikazwe I; Eshun-Wilson I; Sikombe K; Czaicki N; Somwe P; Mody A; Simbeza S; Glidden DV; Chizema E; Mulenga LB; Padian N; Duncombe CJ; Bolton-Moore C; Beres LK; Holmes CB; Geng E
    PLoS Med; 2019 May; 16(5):e1002811. PubMed ID: 31150380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach.
    Geng EH; Bangsberg DR; Musinguzi N; Emenyonu N; Bwana MB; Yiannoutsos CT; Glidden DV; Deeks SG; Martin JN
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):405-11. PubMed ID: 19745753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients who return to care after tracking remain at high risk of attrition: experience from a large HIV clinic, Uganda.
    Nakiwogga-Muwanga A; Musaazi J; Katabira E; Worodria W; Talisuna SA; Colebunders R
    Int J STD AIDS; 2015 Jan; 26(1):42-7. PubMed ID: 24648320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention outcomes and drivers of loss among HIV-exposed and infected infants in Uganda: a retrospective cohort study.
    Kiyaga C; Narayan V; McConnell I; Elyanu P; Kisaakye LN; Kekitiinwa A; Price M; Grosz J
    BMC Infect Dis; 2018 Aug; 18(1):416. PubMed ID: 30134851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of methods for correction of mortality estimates for loss to follow-up after ART initiation: a case of the Infectious Diseases Institute, Uganda.
    Kiragga AN; Castelnuovo B; Musomba R; Levin J; Kambugu A; Manabe YC; Yiannoutsos CT; Kiwanuka N
    PLoS One; 2013; 8(12):e83524. PubMed ID: 24391780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss to follow-up in a cohort of HIV-infected patients in a regional referral outpatient clinic in Brazil.
    de Almeida MC; de Jesus Pedroso N; do Socorro Lina van Keulen M; Jácome GP; Fernandes GC; Yokoo EM; Tuboi SH
    AIDS Behav; 2014 Dec; 18(12):2387-96. PubMed ID: 24917082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.
    Schöni-Affolter F; Keiser O; Mwango A; Stringer J; Ledergerber B; Mulenga L; Bucher HC; Westfall AO; Calmy A; Boulle A; Chintu N; Egger M; Chi BH; ;
    PLoS One; 2011; 6(12):e27919. PubMed ID: 22205933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
    J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Hogg RS; Ford N; Nachega JB; Cooper CL
    J Int AIDS Soc; 2011 Nov; 14():52. PubMed ID: 22050673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.